1 not yet recruiting, 1 recruiting. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Not yet recruiting 1, Recruiting 1 |
Follow Rubidium-82: new trials by email Literature Review of Rubidium-82 trials Research Report on Rubidium-82
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Dynamic 82-Rb Positron Emission Tomography (PET) for the Grading of KIDney Carcinoma 82-Rb injection - Renal Cell Carcinoma | Phase 2 | Not yet recruiting | Assistance Publique - Hôpitaux de Paris | 50 | 2026-01-01 | 2026-01-16 |
| 18F-mFBG Imaging for Myocardial Sympathetic Innervation 18F-metaFluorobenzylguanidine, Rubidium-82 - Heart Failure, Ischemic Cardiomyopathy | Phase 2 | Recruiting | Innervate Radiopharmaceuticals LLC (Formerly: Illumina Radiopharmaceuticals LLC) | 20 | 2025-11-05 | 2026-11-17 |
Carcinoma, Renal Cell (1) · Heart Failure (1) · Neovascularization, Pathologic (1)
Assistance Publique - Hôpitaux de Paris (1) · Innervate Radiopharmaceuticals LLC (Formerly: Illumina Radiopharmaceuticals LLC) (1)
France (1) · United States (1)